• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Protracted hypocalcaemia following a single dose of denosumab in humoral hypercalcaemia of malignancy due to PTHrP-secreting neuroendocrine tumour.

作者信息

Teng Jessie, Abell Sally, Hicks Rodney J, Hofman Michael S, Sachithanandan Nirupa, McKelvie Penny, MacIsaac Richard J

机构信息

Department of Endocrinology and Diabetes, St Vincent's Hospital, Melbourne, Vic., Australia.

出版信息

Clin Endocrinol (Oxf). 2014 Dec;81(6):940-2. doi: 10.1111/cen.12519. Epub 2014 Jul 2.

DOI:10.1111/cen.12519
PMID:24890549
Abstract
摘要

相似文献

1
Protracted hypocalcaemia following a single dose of denosumab in humoral hypercalcaemia of malignancy due to PTHrP-secreting neuroendocrine tumour.因分泌甲状旁腺激素相关蛋白（PTHrP）的神经内分泌肿瘤导致的恶性肿瘤体液性高钙血症患者，单次注射地诺单抗后出现持续性低钙血症。
Clin Endocrinol (Oxf). 2014 Dec;81(6):940-2. doi: 10.1111/cen.12519. Epub 2014 Jul 2.
2
Somatostatin receptor expression in a parathyroid hormone-related peptide-secreting pancreatic neuroendocrine tumour causing severe hypercalcaemia.生长抑素受体在分泌甲状旁腺激素相关肽的胰腺神经内分泌肿瘤中的表达，该肿瘤导致严重高钙血症。
Eur J Gastroenterol Hepatol. 2007 Aug;19(8):719-23. doi: 10.1097/01.meg.0000223908.00987.18.
3
Humoral hypercalcemia of malignancy caused by parathyroid hormone-related peptide-secreting neuroendocrine tumors. Report of six cases.由甲状旁腺激素相关肽分泌的神经内分泌肿瘤引起的恶性肿瘤所致体液性高钙血症。六例报告。
Pancreatology. 2013 May-Jun;13(3):324-6. doi: 10.1016/j.pan.2013.02.007. Epub 2013 Mar 1.
4
Case report of multimodality treatment for metastatic parathyroid hormone-related peptide-secreting pancreatic neuroendocrine tumour.转移性甲状旁腺激素相关肽分泌性胰腺神经内分泌肿瘤的多模态治疗病例报告
Tumori. 2014 Jul-Aug;100(4):153e-6e. doi: 10.1700/1636.17936.
5
PTHrP-Induced Refractory Malignant Hypercalcemia in a Patient With Chronic Lymphocytic Leukemia Responding to Denosumab.一名对地诺单抗有反应的慢性淋巴细胞白血病患者中甲状旁腺激素相关蛋白诱导的难治性恶性高钙血症
Clin Lymphoma Myeloma Leuk. 2015 Sep;15(9):e137-40. doi: 10.1016/j.clml.2015.06.007. Epub 2015 Jun 19.
6
Denosumab is Effective for Controlling Serum Calcium Levels in Patients with Humoral Hypercalcemia of Malignancy Syndrome: A Case Report on Parathyroid Hormone-related Protein-producing Cholangiocarcinoma.地诺单抗对控制恶性肿瘤综合征所致体液性高钙血症患者的血清钙水平有效：一例产生甲状旁腺激素相关蛋白的胆管癌病例报告
Intern Med. 2016;55(23):3453-3457. doi: 10.2169/internalmedicine.55.7134. Epub 2016 Dec 1.
7
Use of denosumab in parathyroid carcinoma with refractory hypercalcemia.地诺单抗在难治性高钙血症甲状旁腺癌中的应用。
QJM. 2015 Jan;108(1):49-50. doi: 10.1093/qjmed/hcu166. Epub 2014 Aug 6.
8
Parathyroid hormone-related peptide-secreting pancreatic neuroendocrine tumours: case series and literature review.分泌甲状旁腺激素相关肽的胰腺神经内分泌肿瘤：病例系列及文献综述
Neuroendocrinology. 2009;89(1):48-55. doi: 10.1159/000151222. Epub 2008 Aug 5.
9
Hypercalcaemia induced by excessive parathyroid hormone secretion in a patient with a neuroendocrine tumour.一名患有神经内分泌肿瘤的患者因甲状旁腺激素分泌过多导致高钙血症。
Nephrol Dial Transplant. 2005 Dec;20(12):2832-5. doi: 10.1093/ndt/gfi065. Epub 2005 Sep 27.
10
Presentation of a PTHrP-secreting pancreatic neuroendocrine tumour, with hypercalcaemic crisis, pre-eclampsia, and renal failure.一例分泌甲状旁腺激素相关蛋白的胰腺神经内分泌肿瘤，伴高钙血症危象、先兆子痫和肾衰竭。
Postgrad Med J. 2002 Dec;78(926):752-3. doi: 10.1136/pmj.78.926.752.

引用本文的文献

1
What Lies behind Paraneoplastic Hypercalcemia Secondary to Well-Differentiated Neuroendocrine Neoplasms? A Systematic Review of the Literature.高分化神经内分泌肿瘤继发副肿瘤性高钙血症的背后是什么？文献系统综述
J Pers Med. 2022 Sep 21;12(10):1553. doi: 10.3390/jpm12101553.
2
Effect of Locally Administered Denosumab on Bone Graft Healing in Rabbit Critical-Size Calvarial Defects.局部应用地诺单抗对兔颅骨临界大小骨缺损骨移植愈合的影响。
Indian J Orthop. 2022 Jun 27;56(8):1424-1430. doi: 10.1007/s43465-022-00673-w. eCollection 2022 Aug.
3
A DRAMATIC RESPONSE TO DENOSUMAB: PROTRACTED HYPOCALCEMIA RELATED TO HUMAN T-CELL LYMPHOTROPIC VIRUS TYPE 1-ASSOCIATED ADULT T-CELL LEUKEMIA/LYMPHOMA.
地诺单抗的显著反应：与人类T细胞嗜淋巴细胞病毒1型相关的成人T细胞白血病/淋巴瘤相关的持续性低钙血症
AACE Clin Case Rep. 2019 Apr 25;5(3):e210-e213. doi: 10.4158/ACCR-2018-0479. eCollection 2019 May-Jun.
4
Prolonged Hypocalcemia Following a Single Dose of Denosumab for Diffuse Bone Metastasis of Gastric Cancer after Total Gastrectomy.全胃切除术后单剂量地诺单抗治疗胃癌弥漫性骨转移后出现的持续性低钙血症
Intern Med. 2017 Nov 1;56(21):2879-2882. doi: 10.2169/internalmedicine.8908-17. Epub 2017 Sep 25.
5
Denosumab is Effective for Controlling Serum Calcium Levels in Patients with Humoral Hypercalcemia of Malignancy Syndrome: A Case Report on Parathyroid Hormone-related Protein-producing Cholangiocarcinoma.地诺单抗对控制恶性肿瘤综合征所致体液性高钙血症患者的血清钙水平有效：一例产生甲状旁腺激素相关蛋白的胆管癌病例报告
Intern Med. 2016;55(23):3453-3457. doi: 10.2169/internalmedicine.55.7134. Epub 2016 Dec 1.
6
Denosumab: a new agent in the management of hypercalcemia of malignancy.地诺单抗：治疗恶性肿瘤高钙血症的新型药物。
Future Oncol. 2015;11(21):2865-71. doi: 10.2217/fon.15.232. Epub 2015 Sep 25.